ON THE TUBERCULIN SUSCEPTIBILITY OF LUNG-CANCER PATIENTS

被引：0
|
作者：
JENSEN, I
机构：
来源：
OFFENTLICHE GESUNDHEITSWESEN | 1980年 / 42卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：311 / 313
页数：3
相关论文
共 50 条
  • [1] CANCER SUSCEPTIBILITY IN RELATIVES OF PATIENTS WITH LUNG-CANCER
    ROTHSCHILD, H
    OOI, WL
    ELSTON, R
    SELLERS, TA
    [J]. CLINICAL RESEARCH, 1986, 34 (02): : A382 - A382
  • [2] LUNG-CANCER, TUBERCULIN REACTIVITY, AND ISONIAZID
    ALHASHIMI, MM
    CITRON, ML
    FOSSIECK, BE
    STEINBERG, SM
    JOHNSTONEARLY, A
    KRASNOW, SH
    COHEN, MH
    [J]. SOUTHERN MEDICAL JOURNAL, 1988, 81 (03) : 337 - 340
  • [3] SUSCEPTIBILITY TO LUNG-CANCER
    AUTRUP, H
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (11): : 1731 - 1731
  • [4] Genetics of lung-cancer susceptibility
    Brennan, Paul
    Hainaut, Pierre
    Boffetta, Paolo
    [J]. LANCET ONCOLOGY, 2011, 12 (04): : 399 - 408
  • [5] INDIVIDUAL SUSCEPTIBILITY TO LUNG-CANCER
    HASDAY, JD
    [J]. PHARMACOGENETICS, 1991, 1 (02): : 107 - 109
  • [6] Is there a lung-cancer susceptibility gene?
    Renan, MJ
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1997, 74 (03) : 359 - 361
  • [7] CANCER SUSCEPTIBILITY IN FAMILIES WITH LUNG-CANCER
    SELLERS, TA
    COHEN, JC
    OOI, WL
    ELSTON, R
    ROTHSCHILD, H
    [J]. CLINICAL RESEARCH, 1986, 34 (01): : A215 - A215
  • [8] DEBRISOQUINE OXIDATION PHENOTYPE AND SUSCEPTIBILITY TO LUNG-CANCER
    BOOBIS, AR
    DAVIES, DS
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (04) : 653 - 656
  • [9] Sex differences in lung-cancer susceptibility explained?
    Larkin, M
    [J]. LANCET, 2000, 355 (9198): : 121 - 121
  • [10] DEBRISOQUIN OXIDATION GENOTYPE AND SUSCEPTIBILITY TO LUNG-CANCER
    AGUNDEZ, JAG
    MARTINEZ, C
    LADERO, JM
    LEDESMA, MC
    RAMOS, JM
    MARTIN, R
    RODRIGUEZ, A
    JARA, C
    BENITEZ, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (01) : 10 - 14
12345